应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02566 九源基因
未开盘 05-12 16:08:12
6.100
+0.010
+0.16%
最高
6.100
最低
5.950
成交量
8.18万
今开
5.960
昨收
6.090
日振幅
2.46%
总市值
14.95亿
流通市值
6.65亿
总股本
2.45亿
成交额
49.39万
换手率
0.08%
流通股本
1.09亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
九源基因:2024年肿瘤产品占营收19.47%,血液产品占9.96%
市场资讯 · 04-29
九源基因:2024年肿瘤产品占营收19.47%,血液产品占9.96%
【九源基因(02566.HK)将于7月30日派发末期股息每10股0.56元】九源基因(02566.HK)发布公告,该公司将于2025年7月30日派发末期股息每10股0.56元人民币。
金融界 · 04-24
【九源基因(02566.HK)将于7月30日派发末期股息每10股0.56元】九源基因(02566.HK)发布公告,该公司将于2025年7月30日派发末期股息每10股0.56元人民币。
九源基因(02566)将于7月30日派发末期股息每10股0.56元
智通财经 · 04-24
九源基因(02566)将于7月30日派发末期股息每10股0.56元
九源基因:2024年收益达人民币1,369.2百万元,同比增长6.4%
金融界 · 04-24
九源基因:2024年收益达人民币1,369.2百万元,同比增长6.4%
九源基因02月26日遭主力抛售18万元
市场透视 · 02-26
九源基因02月26日遭主力抛售18万元
九源基因02月20日获主力加仓27万元
市场透视 · 02-20
九源基因02月20日获主力加仓27万元
九源基因(02566.HK)建议更改公司名称
阿斯达克财经 · 02-13
九源基因(02566.HK)建议更改公司名称
九源基因(02566)拟更名为“杭州九源基因生物医药股份有限公司”
智通财经 · 02-12
九源基因(02566)拟更名为“杭州九源基因生物医药股份有限公司”
九源基因(02566)股价上升6.724%,现价港币$6.19
阿斯达克财经 · 02-07
九源基因(02566)股价上升6.724%,现价港币$6.19
九源基因1月22日收盘下跌1.44%,成交57.05万港元
金融界 · 01-22
九源基因1月22日收盘下跌1.44%,成交57.05万港元
九源基因:聚乙二醇化药物获批上市
和讯网 · 01-21
九源基因:聚乙二醇化药物获批上市
九源基因(02566.HK)吉新芬获国家药监局批准上市
阿斯达克财经 · 01-20
九源基因(02566.HK)吉新芬获国家药监局批准上市
九源基因(02566)股价上升5.254%,现价港币$5.81
阿斯达克财经 · 01-20
九源基因(02566)股价上升5.254%,现价港币$5.81
九源基因1月10日收盘下跌7.04%,成交395.35万港元
金融界 · 01-10
九源基因1月10日收盘下跌7.04%,成交395.35万港元
九源基因盘中最低价触及5.400港元,创近一年新低
金融界 · 01-10
九源基因盘中最低价触及5.400港元,创近一年新低
加载更多
公司概况
公司名称:
九源基因
所属市场:
SEHK
上市日期:
--
主营业务:
杭州九源基因生物医药股份有限公司(原名:杭州九源基因工程股份有限公司)是一家主要从事研发、生产及商业化生物药品和医疗器械的中国公司。该公司专注于骨科、代谢疾病、肿瘤及血液治疗领域。该公司的骨科产品包括骨优导骨修复材料。该公司的肿瘤产品包括吉利芬、吉巨芬、吉欧停、吉芙惟、吉坦苏。该公司的血液产品包括吉派林、亿喏佳。该公司的产品主要用于治疗糖尿病、多发性骨髓瘤、血小板减少症、中性粒细胞减少症等疾病。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"九源基因","latestPrice":6.1,"timestamp":1747037292028,"preClose":6.09,"halted":0,"volume":81800,"delay":0,"floatShares":109000000,"shares":245000000,"eps":0.734356921959125,"marketStatus":"未开盘","change":0.01,"latestTime":"05-12 16:08:12","open":5.96,"high":6.1,"low":5.95,"amount":493930,"amplitude":0.024631,"askPrice":6.11,"askSize":11800,"bidPrice":6.1,"bidSize":200,"shortable":0,"etf":0,"ttmEps":0.734356921959125,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747099800000},"marketStatusCode":0,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":6.09,"dividendRate":0.009863,"openAndCloseTimeList":[[1747013400000,1747022400000],[1747026000000,1747036800000]],"volumeRatio":1.3305139904530154,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02566","defaultTab":"news","newsList":[{"id":"2531216765","title":"九源基因:2024年肿瘤产品占营收19.47%,血液产品占9.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531216765","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531216765?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:25","pubTimestamp":1745889900,"startTime":"0","endTime":"0","summary":"来源:Gangtise投研九源基因(02566.HK)2024年度业绩发布会:九源基因成立于1993年,专注生物医药领域,拥有9款商业化产品,涵盖肿瘤、骨科、血液和代谢四大领域。2024年肿瘤产品占营收19.47%,血液产品占9.96%。其骨科重点产品为国内首款含RHBNP蛋白的骨复合材料,适用于多种骨修复场景。公司正布局院内和院外市场,尤其注重线上互联网药店合作,已与近岸蛋白签署合作协议,共同开发透明质酸酶平台,旨在提升药物渗透分散性,实现给药方式创新。责任编辑:王若云","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429092636a6cc6f5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429092636a6cc6f5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2529648030","title":"【九源基因(02566.HK)将于7月30日派发末期股息每10股0.56元】九源基因(02566.HK)发布公告,该公司将于2025年7月30日派发末期股息每10股0.56元人民币。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529648030","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529648030?lang=zh_cn&edition=full","pubTime":"2025-04-24 12:23","pubTimestamp":1745468623,"startTime":"0","endTime":"0","summary":"九源基因(02566.HK)发布公告,该公司将于2025年7月30日派发末期股息每10股0.56元人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/24122349819418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02566"],"gpt_icon":0},{"id":"2529486816","title":"九源基因(02566)将于7月30日派发末期股息每10股0.56元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529486816","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529486816?lang=zh_cn&edition=full","pubTime":"2025-04-24 12:20","pubTimestamp":1745468433,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九源基因(02566)发布公告,该公司将于2025年7月30日派发末期股息每10股0.56元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566"],"gpt_icon":0},{"id":"2529364877","title":"九源基因:2024年收益达人民币1,369.2百万元,同比增长6.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529364877","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529364877?lang=zh_cn&edition=full","pubTime":"2025-04-24 12:13","pubTimestamp":1745467984,"startTime":"0","endTime":"0","summary":"金融界4月24日消息,九源基因公布2024年年报,期内收益为人民币1,369.2百万元,同比增长6.4%;母公司股东应占年内溢利为人民币138.6百万元;每股基本盈利为人民币0.68元。以上数据未经审核。\n\n\r\n 责任编辑:栎树","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/24121349819071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02566"],"gpt_icon":0},{"id":"2514886189","title":"九源基因02月26日遭主力抛售18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514886189?lang=zh_cn&edition=full","pubTime":"2025-02-26 16:17","pubTimestamp":1740557839,"startTime":"0","endTime":"0","summary":"02月26日, 九源基因股价跌0.43%,报收6.98元,成交金额144万元,换手率0.19%,振幅2.71%,量比0.52。九源基因今日主力资金净流出18万元,上一交易日主力净流出4万元。该股近5个交易日下跌1.13%,主力资金累计净流入41万元;近20日主力资金累计净流入93万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226165106abdd9447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226165106abdd9447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2512410418","title":"九源基因02月20日获主力加仓27万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512410418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512410418?lang=zh_cn&edition=full","pubTime":"2025-02-20 16:15","pubTimestamp":1740039311,"startTime":"0","endTime":"0","summary":"02月20日, 九源基因股价涨0.14%,报收7.07元,成交金额196万元,换手率0.26%,振幅3.12%,量比0.47。九源基因今日主力资金净流入27万元,上一交易日主力净流入2万元。该股近5个交易日上涨14.96%,主力资金累计净流入43万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出39万元,其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220161527abd5ddd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220161527abd5ddd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2511355853","title":"九源基因(02566.HK)建议更改公司名称","url":"https://stock-news.laohu8.com/highlight/detail?id=2511355853","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511355853?lang=zh_cn&edition=full","pubTime":"2025-02-13 08:06","pubTimestamp":1739405160,"startTime":"0","endTime":"0","summary":"九源基因(02566.HK) 公布,其已议决建议将公司的中文名称由“杭州九源基因工程股份有限公司”更改为“杭州九源基因生物医药股份有限公司”,以及将公司的英文名称由“Hangzhou Jiuyuan Gene Engineering Co., Ltd.”更改为“Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.”。九源基因解释,建议更改公司名称旨在全面地反映公司的行业定位,以及准确地反映公司的未来战略发展方向。(js/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241126155522559_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241126155522559_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1416870/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2510308228","title":"九源基因(02566)拟更名为“杭州九源基因生物医药股份有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2510308228","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510308228?lang=zh_cn&edition=full","pubTime":"2025-02-12 22:46","pubTimestamp":1739371616,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九源基因(02566)公布,董事会已议决建议将公司的中文名称由“杭州九源基因工程股份有限公司”更改为“杭州九源基因生物医药股份有限公司”,及将公司的英文名称由“Hangzhou Jiuyuan Gene Engineering Co.,Ltd.”更改为“Hangzhou Jiuyuan Genetic Biopharmaceutical Co.,Ltd.”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","161726","02566"],"gpt_icon":0},{"id":"2509678897","title":"九源基因(02566)股价上升6.724%,现价港币$6.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2509678897","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509678897?lang=zh_cn&edition=full","pubTime":"2025-02-07 14:48","pubTimestamp":1738910880,"startTime":"0","endTime":"0","summary":"[上升股]九源基因(02566) 股价在下午02:48比前收市价上升6.724%,现股价为港币$6.19。至目前为止,今日最高价为$6.19,而最低价为$5.7。总成交量为21万股,总成交金额为港币$122.886万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502074530/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2505713634","title":"九源基因1月22日收盘下跌1.44%,成交57.05万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505713634","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505713634?lang=zh_cn&edition=full","pubTime":"2025-01-22 16:59","pubTimestamp":1737536379,"startTime":"0","endTime":"0","summary":"1月22日,截至港股收盘,恒生指数下跌1.63%,报19778.77点。九源基因收报5.49港元/股,下跌1.44%,成交量10.26万股,成交额57.05万港元,振幅3.05%。最近一个月来,九源基因累计跌幅19.5%,今年来累计跌幅16.82%,跑输恒生指数-1.4%的跌幅。财务数据显示,截至2024年6月30日,九源基因实现营业总收入7.02亿元,同比增长5.87%;归母净利润1.05亿元,同比增长9.33%;毛利率76.96%,资产负债率29.96%。机构评级方面,目前暂无机构对该股做出投资评级建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122170407986f2781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122170407986f2781&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2505959132","title":"九源基因:聚乙二醇化药物获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2505959132","media":"和讯网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505959132?lang=zh_cn&edition=full","pubTime":"2025-01-21 09:33","pubTimestamp":1737423225,"startTime":"0","endTime":"0","summary":"【九源基因:聚乙二醇化人粒细胞刺激因子注射液获批上市】九源基因公布,其聚乙二醇化人粒细胞刺激因子注射液已获国家药品监督管理局批准上市。该注射液用于治疗成年非髓性恶性肿瘤患者,可降低相关感染发生率。其由人粒细胞刺激因子与 20KD 聚乙二醇交联并经纯化获得,具有诸多优点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121103708986d7c8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121103708986d7c8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2505233999","title":"九源基因(02566.HK)吉新芬获国家药监局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2505233999","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505233999?lang=zh_cn&edition=full","pubTime":"2025-01-21 01:12","pubTimestamp":1737393120,"startTime":"0","endTime":"0","summary":"九源基因(02566.HK) 公布,聚乙二醇化人粒细胞刺激因子注射液(商标名︰吉新芬)已获中国国家药监局批准上市,用于治疗成年非髓性恶性肿瘤患者在接受易引起发热性中性粒细胞减少症的骨髓抑制性抗癌药物治疗时,降低以发热性中性粒细胞减 少症为表现的感染发生率。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241126155526856_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241126155526856_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1411882/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2504644540","title":"九源基因(02566)股价上升5.254%,现价港币$5.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2504644540","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504644540?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:30","pubTimestamp":1737340200,"startTime":"0","endTime":"0","summary":"[上升股]九源基因(02566) 股价在上午10:30比前收市价上升5.254%,现股价为港币$5.81。至目前为止,今日最高价为$5.81,而最低价为$5.54。总成交量为1.92万股,总成交金额为港币$10.875万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2501203437/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2502367896","title":"九源基因1月10日收盘下跌7.04%,成交395.35万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502367896","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502367896?lang=zh_cn&edition=full","pubTime":"2025-01-10 17:20","pubTimestamp":1736500852,"startTime":"0","endTime":"0","summary":"1月10日,截至港股收盘,恒生指数下跌0.92%,报19064.29点。九源基因收报5.41港元/股,下跌7.04%,成交量71.62万股,成交额395.35万港元,振幅7.22%。最近一个月来,九源基因累计跌幅26.99%,今年来累计跌幅18.03%,跑输恒生指数-4.96%的跌幅。财务数据显示,截至2024年6月30日,九源基因实现营业总收入7.02亿元,同比增长5.87%;归母净利润1.05亿元,同比增长9.33%;毛利率76.96%,资产负债率29.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011017231395ff1449&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011017231395ff1449&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2502131899","title":"九源基因盘中最低价触及5.400港元,创近一年新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2502131899","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502131899?lang=zh_cn&edition=full","pubTime":"2025-01-10 16:34","pubTimestamp":1736498083,"startTime":"0","endTime":"0","summary":"截至1月10日收盘,九源基因报5.410港元,较上个交易日下跌7.04%,当日盘中最低价触及5.400港元,创近一年新低。资金流向方面,当日主力流入89.917万港元,流出262.296万港元,净流出172.38万港元。杭州九源基因工程股份有限公司于1993年创立,是一家总部设于浙江省的中国生物制药公司,拥有逾30年生物药品及医疗器械研发、生产及商业化经验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011016380095ff056d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011016380095ff056d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-gene.com","stockEarnings":[{"period":"1week","weight":0.0201},{"period":"1month","weight":0.0357},{"period":"3month","weight":-0.0145},{"period":"6month","weight":-0.5089},{"period":"ytd","weight":-0.0758}],"compareEarnings":[{"period":"1week","weight":0.0464},{"period":"1month","weight":0.126},{"period":"3month","weight":0.1059},{"period":"6month","weight":0.188},{"period":"1year","weight":0.2418},{"period":"ytd","weight":0.174}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州九源基因生物医药股份有限公司(原名:杭州九源基因工程股份有限公司)是一家主要从事研发、生产及商业化生物药品和医疗器械的中国公司。该公司专注于骨科、代谢疾病、肿瘤及血液治疗领域。该公司的骨科产品包括骨优导骨修复材料。该公司的肿瘤产品包括吉利芬、吉巨芬、吉欧停、吉芙惟、吉坦苏。该公司的血液产品包括吉派林、亿喏佳。该公司的产品主要用于治疗糖尿病、多发性骨髓瘤、血小板减少症、中性粒细胞减少症等疾病。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"九源基因","nameEN":"JIUYUAN GENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九源基因(02566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九源基因,02566,九源基因股票,九源基因股票老虎,九源基因股票老虎国际,九源基因行情,九源基因股票行情,九源基因股价,九源基因股市,九源基因股票价格,九源基因股票交易,九源基因股票购买,九源基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九源基因(02566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}